David Rubin

Cognia, Inc. operates molecular information centers. It engages in the development and distribution of information solutions for pharmaceutical, scientific research, and biotechnology communities in the United States. The company was founded in 1999 and is headquartered in New York, NY.

Merck Global Health Innovation LLC (Merck Global Health) is a venture capital subsidiary of Merck & Co., Inc. founded in 2010. The firm is headquartered in Rahway, New Jersey.

VirtualScopics, Inc. provides quantitative imaging solutions currently serving the pharmaceutical, biotechnology and medical device industries. It provides image analysis software tools and applications which are used in detecting and measuring specific anatomical structures and metabolic activity using medical images. The company's therapeutic area expertise includes oncology, rheumatoid arthritis, osteoarthritis, neurology, cardiovascular, muscle and fat measurements and COPD studies utilizing MRI, PET, CT, Ultrasound and X-Ray imaging modalities. VirtualScopics was founded by Saara Totterman, Kevin J. Parker, Jose Tamez-Pena and Edward Ashton in July 2000 and is headquartered in Rochester, NY.

Daktari Diagnostics, Inc. operates as a holding company that provides healthcare solutions. The firm engages in the development of point-of-care diagnostic systems for global health applications. Its product includes Daktari Virology which detects HIV and HCV, Daktari InSight which provides data management services, and Daktari Sickle Cell which detects sickle cell disease on infants. The company was founded by William Rodriguez in 2008 and is headquartered in Cambridge, MA.

Aviir, Inc. discovers, develops and commercializes diagnostic laboratory tests for cardiovascular diseases. The biotechnology company specializes in developing proprietary diagnostic tests to assist in identifying patients who are truly at high risk for the development of a cardiac event. The company was founded in 2005 and is headquartered in Irvine, CA.

AdvanDx, Inc. provides advanced molecular diagnostic products for the prevention, diagnosis and treatment of life-threatening, bacterial infections. Its products include QuickFISH BC Tests, PNA FISH Tests, ASR PNA Probes, starter system, accessories and package inserts. The firm offers diagnostic solutions that include antimicrobial stewardship, blood culture contamination, staphylococcal bacteremia, enterococcal bacteremia, gram-negative bacteremia and candidemia. The company was founded by Henrik Stender and Thais T. Johansen in 2002 and is headquartered in Woburn, MA.

Asuragen, Inc. develops molecular diagnostic products. Its products include AmplideX and QuantideX. It uses genomics to drive patient management through clinical testing solutions. The company was founded in March 2006 by Matthew M. Winkler and is headquartered in Austin, TX.